WITHDRAWN: Probable relapse of anti-NMDAR encephalitis with seizures as first symptom: A report of two cases and literature review

Vitaliani, 2005, Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma, Ann. Neurol., 58, 594, 10.1002/ana.20614 Sansing, 2007, A patient with encephalitis associated with NMDA receptor antibodies, Nat. Clin. Pract. Neurol., 3, 291, 10.1038/ncpneuro0493 Iizuka, 2008, Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal, Neurology, 70, 504, 10.1212/01.wnl.0000278388.90370.c3 Dalmau, 2011, Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis, Lancet Neurol., 10, 63, 10.1016/S1474-4422(10)70253-2 Dalmau, 2008, Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies, Lancet Neurol., 7, 1091, 10.1016/S1474-4422(08)70224-2 Florance, 2009, Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents, Ann. Neurol., 66, 11, 10.1002/ana.21756 Gabilondo, 2011, Analysis of relapses in anti-NMDAR encephalitis, Neurology, 77, 996, 10.1212/WNL.0b013e31822cfc6b Wickstrom, 2014, Viral triggering of anti-NMDA receptor encephalitis in a child - an important cause for disease relapse, Eur. J. Paediatr. Neurol., 18, 543, 10.1016/j.ejpn.2014.03.011 Hacohen, 2014, N-methyl-d-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse, Mov. Disord., 29, 90, 10.1002/mds.25626 Titulaer, 2014, Seizures as first symptom of anti-NMDA receptor encephalitis are more common in men, Neurology, 82, 550, 10.1212/WNL.0000000000000131